United Kingdom (UK) Intravenous Immunoglobulin Market (2025-2031) | Analysis, Outlook, Companies, Competitive Landscape, Size & Revenue, Trends, Value, Growth, Segmentation, Forecast, Share, Industry

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 United Kingdom (UK) Country Macro Economic Indicators

3.2 United Kingdom (UK) Intravenous Immunoglobulin Market Revenues & Volume, 2021 & 2031F

3.3 United Kingdom (UK) Intravenous Immunoglobulin Market - Industry Life Cycle

3.4 United Kingdom (UK) Intravenous Immunoglobulin Market - Porter's Five Forces

3.5 United Kingdom (UK) Intravenous Immunoglobulin Market Revenues & Volume Share, By Indication, 2021 & 2031F

3.6 United Kingdom (UK) Intravenous Immunoglobulin Market Revenues & Volume Share, By End-user, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of autoimmune diseases and primary immunodeficiency disorders in the UK

4.2.2 Growing awareness about the benefits of intravenous immunoglobulin therapy

4.2.3 Continuous advancements in biotechnology and healthcare infrastructure in the UK

4.3 Market Restraints

4.3.1 High cost associated with intravenous immunoglobulin therapy

4.3.2 Stringent regulatory requirements for the approval and distribution of intravenous immunoglobulin products in the UK

6.1 United Kingdom (UK) Intravenous Immunoglobulin Market, By Indication

6.1.1 Overview and Analysis

6.1.2 United Kingdom (UK) Intravenous Immunoglobulin Market Revenues & Volume, By Indication, 2021- 2031F

6.1.3 United Kingdom (UK) Intravenous Immunoglobulin Market Revenues & Volume, By Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), 2021- 2031F

6.1.4 United Kingdom (UK) Intravenous Immunoglobulin Market Revenues & Volume, By Primary Humoral Immunodeficiency, 2021- 2031F

6.1.5 United Kingdom (UK) Intravenous Immunoglobulin Market Revenues & Volume, By Idiopathic Thrombocytopenic Purpura (ITP), 2021- 2031F

6.1.6 United Kingdom (UK) Intravenous Immunoglobulin Market Revenues & Volume, By Guillain-Barre Syndrome, 2021- 2031F

6.1.7 United Kingdom (UK) Intravenous Immunoglobulin Market Revenues & Volume, By Myasthenia Gravis, 2021- 2031F

6.1.8 United Kingdom (UK) Intravenous Immunoglobulin Market Revenues & Volume, By Multifocal Motor Neuropathy (MMN), 2021- 2031F

6.1.9 United Kingdom (UK) Intravenous Immunoglobulin Market Revenues & Volume, By Others, 2021- 2031F

6.1.10 United Kingdom (UK) Intravenous Immunoglobulin Market Revenues & Volume, By Others, 2021- 2031F

6.2 United Kingdom (UK) Intravenous Immunoglobulin Market, By End-user

6.2.1 Overview and Analysis

6.2.2 United Kingdom (UK) Intravenous Immunoglobulin Market Revenues & Volume, By Hospitals, 2021- 2031F

6.2.3 United Kingdom (UK) Intravenous Immunoglobulin Market Revenues & Volume, By Clinics, 2021- 2031F

6.2.4 United Kingdom (UK) Intravenous Immunoglobulin Market Revenues & Volume, By Home Care, 2021- 2031F

7.1 United Kingdom (UK) Intravenous Immunoglobulin Market Export to Major Countries

7.2 United Kingdom (UK) Intravenous Immunoglobulin Market Imports from Major Countries

8.1 Patient adherence and compliance rates with intravenous immunoglobulin therapy

8.2 Number of clinical trials and research studies conducted on intravenous immunoglobulin in the UK

8.3 Rate of adoption of intravenous immunoglobulin therapy by healthcare facilities in the UK

9.1 United Kingdom (UK) Intravenous Immunoglobulin Market Opportunity Assessment, By Indication, 2021 & 2031F

9.2 United Kingdom (UK) Intravenous Immunoglobulin Market Opportunity Assessment, By End-user, 2021 & 2031F

10.1 United Kingdom (UK) Intravenous Immunoglobulin Market Revenue Share, By Companies, 2024

10.2 United Kingdom (UK) Intravenous Immunoglobulin Market Competitive Benchmarking, By Operating and Technical Parameters